Titlebook: Cancer Genetics; Boris Pasche Book 2010 Springer Science+Business Media, LLC 2010 Colorectal cancer.GIST.Methylation.Ovarian Cancer.Paraga

猛烈抨擊

書目名稱Cancer Genetics影響因子(影響力)




書目名稱Cancer Genetics影響因子(影響力)學(xué)科排名




書目名稱Cancer Genetics網(wǎng)絡(luò)公開度




書目名稱Cancer Genetics網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cancer Genetics被引頻次




書目名稱Cancer Genetics被引頻次學(xué)科排名




書目名稱Cancer Genetics年度引用




書目名稱Cancer Genetics年度引用學(xué)科排名




書目名稱Cancer Genetics讀者反饋




書目名稱Cancer Genetics讀者反饋學(xué)科排名

Expediency

Genetics and Genomics of Neuroblastoma,discover genetic factors predisposing to tumor initiation such as rare mutations at locus 2p23 (in . gene) for familial neuroblastoma, common SNPs at 6p22 (. and .) and 2q35 (.), and a copy number polymorphism at 1q21.1 (.) for sporadic neuroblastoma. It also deals with well known and recently repor

probate

,TGF-β Signaling Alterations and Colon Cancer,es during embryonic development, and in adult organisms they play a role in tissue homeostasis. TGF-β has a central role in inhibiting cell proliferation and also modulates processes such as cell invasion, immune regulation, and microenvironment modification. Mutations in the TGF-β type II receptor

Nutrient

不能妥協(xié)

GLUE

https://doi.org/10.1007/978-3-319-69416-0es during embryonic development, and in adult organisms they play a role in tissue homeostasis. TGF-β has a central role in inhibiting cell proliferation and also modulates processes such as cell invasion, immune regulation, and microenvironment modification. Mutations in the TGF-β type II receptor

GLUE

Timothy E. O’Brien,Changwon Lim These include issues such as appropriate testing of children and embryos, the “duty to warn” relatives about familial risk, reproductive genetic testing, the risk of genetic discrimination, and equitable access to testing. These and other issues will be discussed within the framework of a bioethica

libertine

Georgios Afendras,Marianthi Markatouof cases are accounted for by high-penetrance monogenic predisposition genes; however, this explains only a small fraction (less than 5%) of all breast cancers. Increasingly with advances in molecular technology and the development of large research consortia, the locations and identities of many lo

偶然

TRAWL

Georgios Afendras,Marianthi Markatoutric problem because it accounts for approximately 15% of childhood cancer mortality. The disease is clinically heterogeneous, with the likelihood of cure varying greatly according to age at diagnosis, extent of disease, and tumor biology. This extreme clinical heterogeneity reflects the complexity